The Drug Controller General of India (DGCI) on Saturday gave Bharat Biotech approval for emergency use authorisation of Covaxin Covid-19 vaccine for children in the 12-18 years age group, according to reports. The Subject Expert Committee (SEC) had in October recommended DGCI to grant emergency use authorisation to Covaxin for children. Covaxin became the second vaccine cleared for use for children in India. In August, Zydus Cadila’s three-dose DNA jab was allowed to be used on adults and children over 12.Read all the Latest News, Breaking News and Coronavirus News here.